Correction: Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

J Exp Clin Cancer Res. 2023 Sep 16;42(1):241. doi: 10.1186/s13046-023-02818-7.NO ABSTRACTPMID:37715266 | PMC:PMC10504694 | DOI:10.1186/s13046-023-02818-7
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Source Type: research